Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$10.36
-0.9%
$8.74
$6.85
$10.79
$524.60M1.61454,151 shs238,841 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.58
-0.8%
$3.82
$2.21
$6.30
$133.01M-0.0582,464 shs56,833 shs
InnovAge Holding Corp. stock logo
INNV
InnovAge
$4.05
+0.2%
$3.22
$2.60
$6.69
$546.80M0.452,448 shs46,758 shs
Personalis, Inc. stock logo
PSNL
Personalis
$4.70
+0.2%
$3.92
$1.14
$7.20
$415.13M1.831.01 million shs617,710 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
+2.00%-1.42%+33.76%+26.15%+17.87%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-3.99%-6.96%-5.74%-5.25%+54.27%
InnovAge Holding Corp. stock logo
INNV
InnovAge
+2.80%-4.72%+31.60%+24.69%-10.22%
Personalis, Inc. stock logo
PSNL
Personalis
-1.88%-5.44%+22.14%+4.69%+250.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Enhabit, Inc. stock logo
EHAB
Enhabit
1.996 of 5 stars
1.05.00.00.03.50.82.5
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.4917 of 5 stars
0.03.00.00.02.90.00.6
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.9631 of 5 stars
1.82.00.00.02.91.70.6
Personalis, Inc. stock logo
PSNL
Personalis
4.3558 of 5 stars
3.54.00.04.22.52.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enhabit, Inc. stock logo
EHAB
Enhabit
2.00
Hold$8.50-17.95% Downside
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.50
Reduce$5.0023.46% Upside
Personalis, Inc. stock logo
PSNL
Personalis
3.00
Buy$7.6763.12% Upside

Current Analyst Ratings Breakdown

Latest EUDA, EHAB, INNV, and PSNL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Personalis, Inc. stock logo
PSNL
Personalis
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
5/7/2025
Personalis, Inc. stock logo
PSNL
Personalis
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $9.00
4/10/2025
Personalis, Inc. stock logo
PSNL
Personalis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
3/17/2025
Personalis, Inc. stock logo
PSNL
Personalis
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$8.00
3/6/2025
Enhabit, Inc. stock logo
EHAB
Enhabit
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
2/28/2025
Personalis, Inc. stock logo
PSNL
Personalis
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
2/28/2025
Personalis, Inc. stock logo
PSNL
Personalis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.25 ➝ $7.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.51$3.19 per share3.25$13.90 per share0.75
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M33.16N/AN/A($0.30) per share-11.93
InnovAge Holding Corp. stock logo
INNV
InnovAge
$831.68M0.66N/AN/A$1.90 per share2.13
Personalis, Inc. stock logo
PSNL
Personalis
$85.69M4.84N/AN/A$2.64 per share1.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enhabit, Inc. stock logo
EHAB
Enhabit
-$80.50M-$2.77N/A35.72N/A-11.24%1.67%0.80%8/5/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$10.04MN/A0.00N/AN/AN/AN/AN/A5/30/2025 (Estimated)
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$21.34M-$0.23N/A67.50N/A-3.19%-9.45%-4.84%N/A
Personalis, Inc. stock logo
PSNL
Personalis
-$108.30M-$1.29N/AN/AN/A-104.52%-66.07%-41.34%8/6/2025 (Estimated)

Latest EUDA, EHAB, INNV, and PSNL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
5/6/2025Q3 2025
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 million
5/6/2025Q1 2025
Personalis, Inc. stock logo
PSNL
Personalis
-$0.23-$0.18+$0.05-$0.18$17.41 million$20.61 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
N/AN/AN/AN/AN/A
Personalis, Inc. stock logo
PSNL
Personalis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enhabit, Inc. stock logo
EHAB
Enhabit
0.85
1.46
1.46
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.13
N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.27
1.16
1.16
Personalis, Inc. stock logo
PSNL
Personalis
N/A
4.68
4.44

Institutional Ownership

CompanyInstitutional Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
InnovAge Holding Corp. stock logo
INNV
InnovAge
12.26%
Personalis, Inc. stock logo
PSNL
Personalis
61.91%

Insider Ownership

CompanyInsider Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
1.90%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.40%
Personalis, Inc. stock logo
PSNL
Personalis
3.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,90050.64 million49.33 millionOptionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
237.15 millionN/ANot Optionable
InnovAge Holding Corp. stock logo
INNV
InnovAge
2,000135.01 million133.35 millionOptionable
Personalis, Inc. stock logo
PSNL
Personalis
40088.33 million67.75 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enhabit stock logo

Enhabit NYSE:EHAB

$10.36 -0.09 (-0.86%)
Closing price 03:59 PM Eastern
Extended Trading
$10.36 +0.01 (+0.05%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$3.58 -0.03 (-0.83%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

InnovAge stock logo

InnovAge NASDAQ:INNV

$4.05 +0.01 (+0.25%)
Closing price 04:00 PM Eastern
Extended Trading
$4.09 +0.04 (+0.99%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Personalis stock logo

Personalis NASDAQ:PSNL

$4.70 +0.01 (+0.21%)
Closing price 04:00 PM Eastern
Extended Trading
$4.71 +0.01 (+0.21%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.